Literature DB >> 29898151

Percutaneous Lead Extraction in Infection of Cardiac Implantable Electronic Devices: a Systematic Review.

Antônio da Silva Menezes Júnior1, Thaís Rodrigues Magalhães1, Alana de Oliveira Alarcão Morais1.   

Abstract

INTRODUCTION: In the last two decades, the increased number of implants of cardiac implantable electronic devices has been accompanied by an increase in complications, especially infection. Current recommendations for the appropriate treatment of cardiac implantable electronic devices-related infections consist of prolonged antibiotic therapy associated with complete device extraction. The purpose of this study was to analyze the importance of percutaneous extraction in the treatment of these devices infections.
METHODS: A systematic review search was performed in the PubMed, BVS, Cochrane CENTRAL, CAPES, SciELO and ScienceDirect databases. A total of 1,717 studies were identified and subsequently selected according to the eligibility criteria defined by relevance tests by two authors working independently.
RESULTS: Sixteen studies, describing a total of 3,354 patients, were selected. Percutaneous extraction was performed in 3,081 patients. The average success rate for the complete percutaneous removal of infected devices was 92.4%. Regarding the procedure, the incidence of major complications was 2.9%, and the incidence of minor complications was 8.4%. The average in-hospital mortality of the patients was 5.4%, and the mortality related to the procedure ranged from 0.4 to 3.6%. The mean mortality was 20% after 6 months and 14% after a one-year follow-up.
CONCLUSION: Percutaneous extraction is the main technique for the removal of infected cardiac implantable electronic devices, and it presents low rates of complications and mortality related to the procedure.

Entities:  

Mesh:

Year:  2018        PMID: 29898151      PMCID: PMC5985848          DOI: 10.21470/1678-9741-2017-0144

Source DB:  PubMed          Journal:  Braz J Cardiovasc Surg        ISSN: 0102-7638


  36 in total

1.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).

Authors:  Bruce L Wilkoff; Charles J Love; Charles L Byrd; Maria Grazia Bongiorni; Roger G Carrillo; George H Crossley; Laurence M Epstein; Richard A Friedman; Charles E H Kennergren; Przemyslaw Mitkowski; Raymond H M Schaerf; Oussama M Wazni
Journal:  Heart Rhythm       Date:  2009-05-22       Impact factor: 6.343

2.  Complete removal as a routine treatment for any cardiovascular implantable electronic device-associated infection.

Authors:  Maximilian Pichlmaier; Ludmilla Knigina; Ingo Kutschka; Christoph Bara; Hanno Oswald; Gunnar Klein; Theodosius Bisdas; Axel Haverich
Journal:  J Thorac Cardiovasc Surg       Date:  2011-05-12       Impact factor: 5.209

3.  16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.

Authors:  Arnold J Greenspon; Jasmine D Patel; Edmund Lau; Jorge A Ochoa; Daniel R Frisch; Reginald T Ho; Behzad B Pavri; Steven M Kurtz
Journal:  J Am Coll Cardiol       Date:  2011-08-30       Impact factor: 24.094

4.  Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram.

Authors:  Jon A Grammes; Christopher M Schulze; Mohammad Al-Bataineh; George A Yesenosky; Christine S Saari; Michelle J Vrabel; Jay Horrow; Mashiul Chowdhury; John M Fontaine; Steven P Kutalek
Journal:  J Am Coll Cardiol       Date:  2010-03-02       Impact factor: 24.094

5.  Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections.

Authors:  Katherine Y Le; Muhammad R Sohail; Paul A Friedman; Daniel Z Uslan; Stephen S Cha; David L Hayes; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  Heart Rhythm       Date:  2011-05-27       Impact factor: 6.343

6.  Pacemaker infective endocarditis.

Authors:  P Cacoub; P Leprince; P Nataf; P Hausfater; R Dorent; B Wechsler; V Bors; A Pavie; J C Piette; I Gandjbakhch
Journal:  Am J Cardiol       Date:  1998-08-15       Impact factor: 2.778

7.  Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival.

Authors:  Khaldoun G Tarakji; Oussama M Wazni; Serge Harb; Amy Hsu; Walid Saliba; Bruce L Wilkoff
Journal:  Europace       Date:  2014-08-02       Impact factor: 5.214

8.  Lead Extraction for Treatment of Cardiac Device Infection: A 20-Year Single Centre Experience.

Authors:  Sean Gomes; Gregory Cranney; Michael Bennett; Robert Giles
Journal:  Heart Lung Circ       Date:  2016-08-12       Impact factor: 2.975

9.  Survival of patients with biventricular devices after device infection, extraction, and reimplantation.

Authors:  John Rickard; Khaldoun Tarakji; Alan Cheng; David Spragg; Daniel J Cantillon; David O Martin; Bryan Baranowski; Steven M Gordon; W H Wilson Tang; Mohammed Kanj; Oussama Wazni; Bruce L Wilkoff
Journal:  JACC Heart Fail       Date:  2013-12-02       Impact factor: 12.035

10.  Risk factors for mortality in patients with cardiac device-related infection.

Authors:  Timir S Baman; Sanjaya K Gupta; Javier A Valle; Elina Yamada
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02-13
View more
  1 in total

1.  Laser Lead Extraction During Venoarterial ECMO support.

Authors:  Yalin Yildirim; Johannes Petersen; Tobias Tönnis; Christian Detter; Hermann Reichenspurner; Simon Pecha
Journal:  Braz J Cardiovasc Surg       Date:  2022-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.